PDI inks deal with 'top-five' pharma company

PDI has inked a deal with an undisclosed “top-five pharmaceutical company” expected to generate $23 million in revenue for the contract sales firm over its one-year term. PDI said the deal will target primary care physicians and specialty audiences.
You must be a registered member of MMM to post a comment.

Next Article in Pharmaceutical